ADAM17-dependent signaling is required for oncogenic human papillomavirus entry platform assembly

dc.contributor.authorMikuličić, Snježana
dc.contributor.authorFinke, Jérôme
dc.contributor.authorBoukhallouk, Fatima
dc.contributor.authorWüstenhagen, Elena
dc.contributor.authorSons, Dominik
dc.contributor.authorHomsi, Yahya
dc.contributor.authorReiss, Karina
dc.contributor.authorLang, Thorsten
dc.contributor.authorFlorin, Luise
dc.date.accessioned2019-07-08T11:12:53Z
dc.date.available2019-07-08T13:12:53Z
dc.date.issued2019
dc.description.abstractOncogenic human papillomaviruses (HPV) are small DNA viruses that infect keratinocytes. After HPV binding to cell surface receptors, a cascade of molecular interactions mediates the infectious cellular internalization of virus particles. Aside from the virus itself, important molecular players involved in virus entry include the tetraspanin CD151 and the epidermal growth factor receptor (EGFR). To date, it is unknown how these components are coordinated in space and time. Here, we studied plasma membrane dynamics of CD151 and EGFR and the HPV16 capsid during the early phase of infection. We find that the proteinase ADAM17 activates the extracellular signal-regulated kinases (ERK1/2) pathway by the shedding of growth factors which triggers the formation of an endocytic entry platform. Infectious endocytic entry platforms carrying virus particles consist of two-fold larger CD151 domains containing the EGFR. Our finding clearly dissects initial virus binding from ADAM17-dependent assembly of a HPV/CD151/EGFR entry platform.en_GB
dc.description.sponsorshipDFG, Open Access-Publizieren Universität Mainz / Universitätsmedizin
dc.identifier.doihttp://doi.org/10.25358/openscience-166
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/168
dc.identifier.urnurn:nbn:de:hebis:77-publ-591345
dc.language.isoeng
dc.rightsCC-BY-4.0de_DE
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleADAM17-dependent signaling is required for oncogenic human papillomavirus entry platform assemblyen_GB
dc.typeZeitschriftenaufsatzde_DE
jgu.journal.titleeLife
jgu.journal.volume8
jgu.organisation.departmentFB 04 Medizin
jgu.organisation.nameJohannes Gutenberg-Universität Mainz
jgu.organisation.number2700
jgu.organisation.placeMainz
jgu.organisation.rorhttps://ror.org/023b0x485
jgu.pages.alternativee44345
jgu.publisher.doi10.7554/eLife.44345.001
jgu.publisher.issn2050-084X
jgu.publisher.nameeLife Sciences Publications
jgu.publisher.placeCambridge
jgu.publisher.urihttp://dx.doi.org/10.7554/eLife.44345.001
jgu.publisher.year2019
jgu.rights.accessrightsopenAccess
jgu.subject.ddccode610
jgu.type.dinitypeArticle
jgu.type.resourceText
jgu.type.versionPublished versionen_GB
opus.affiliatedBoukhallouk, Fatima
opus.affiliatedFlorin, Luise
opus.date.accessioned2019-07-08T11:12:53Z
opus.date.available2019-07-08T13:12:53
opus.date.modified2019-07-09T08:35:31Z
opus.identifier.opusid59134
opus.institute.number0409
opus.institute.number0476
opus.institute.number0408
opus.metadataonlyfalse
opus.organisation.stringFB 04: Medizin: Institut für Virologiede_DE
opus.organisation.stringFB 04: Medizin: Forschungszentrum für Immuntherapie (FZI)de_DE
opus.organisation.stringFB 04: Medizin: Institut für Medizinische Mikrobiologie und Hygienede_DE
opus.subject.dfgcode00-000
opus.type.contenttypeKeinede_DE
opus.type.contenttypeNoneen_GB

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
59134.pdf
Size:
3.81 MB
Format:
Adobe Portable Document Format